Allergan to buy experimental psoriasis drugmaker Vitae for $639 mln

NEW YORK, Sept 14 (Reuters) - Allergan Inc on
Wednesday said it would buy Vitae Pharmaceuticals,
which is testing an experimental drug to treat psoriasis and
other autoimmune disorders, for $639...